About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed CONSTIPATION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ALIZAPRIDE reported CONSTIPATION to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and CONSTIPATION. In doing so, we compare ALIZAPRIDE with other drugs that cause CONSTIPATION, to help you evaluate whether or not ALIZAPRIDE causes CONSTIPATION. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if CONSTIPATION ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing CONSTIPATION: 2
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where CONSTIPATION is a reported side effect: 1.9608%

FDA reports of any drug causing CONSTIPATION : 46656
Average percentage for all medicated patients where CONSTIPATION is reported as a complication: 0.2924%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with CONSTIPATION:

FOSAMAX (5673 patients)
ASPIRIN (4491 patients)
VIOXX (3154 patients)
ZOMETA (2855 patients)
CHANTIX (2488 patients)
FORTEO (2430 patients)
LIPITOR (2425 patients)
SEROQUEL (2215 patients)
NEXIUM (2114 patients)
OXYCONTIN (2101 patients)
SYNTHROID (1912 patients)
LASIX (1797 patients)
LISINOPRIL (1776 patients)
NEURONTIN (1742 patients)
PREDNISONE (1740 patients)
ALLI (1709 patients)
LYRICA (1691 patients)
OMEPRAZOLE (1567 patients)
AMBIEN (1547 patients)
XANAX (1509 patients)
DEXAMETHASONE (1482 patients)
COUMADIN (1472 patients)
CYMBALTA (1459 patients)
BYETTA (1450 patients)
PRILOSEC (1441 patients)
ZOLOFT (1424 patients)
AREDIA (1400 patients)
REVLIMID (1393 patients)
PROTONIX (1312 patients)
FUROSEMIDE (1308 patients)
OXYCODONE HCL (1289 patients)
FOLIC ACID (1281 patients)
LORAZEPAM (1274 patients)
PERCOCET (1261 patients)
CELEBREX (1261 patients)
ALBUTEROL (1260 patients)
ATENOLOL (1259 patients)
HYDROCHLOROTHIAZIDE (1249 patients)
VICODIN (1237 patients)
ACETAMINOPHEN (1232 patients)
DURAGESIC-100 (1224 patients)
PREVACID (1206 patients)
VITAMIN D (1158 patients)
ZOCOR (1156 patients)
NORVASC (1115 patients)
ZOFRAN (1100 patients)
SPIRIVA (1095 patients)
SIMVASTATIN (1092 patients)
DECADRON (1091 patients)
TOPROL-XL (1071 patients)
PLAVIX (1070 patients)
MORPHINE (1069 patients)
LEXAPRO (1052 patients)
ATIVAN (1048 patients)
LEVOTHYROXINE SODIUM (1047 patients)
METFORMIN HCL (1042 patients)
PAXIL (1005 patients)
HUMIRA (1000 patients)
GABAPENTIN (984 patients)
CRESTOR (971 patients)
CALCIUM (957 patients)
IBUPROFEN (940 patients)
POTASSIUM CHLORIDE (936 patients)
CLOZARIL (898 patients)
ACCUTANE (879 patients)
LEVAQUIN (862 patients)
ALLOPURINOL (854 patients)
EFFEXOR (848 patients)
VELCADE (848 patients)
MIRALAX (838 patients)
NEXAVAR (828 patients)
METHOTREXATE (816 patients)
CLONAZEPAM (809 patients)
ADVAIR DISKUS 100/50 (805 patients)
LORTAB (787 patients)
COLACE (775 patients)
LACTULOSE (769 patients)
PREDNISOLONE (762 patients)
PROZAC (753 patients)
ALPRAZOLAM (743 patients)
CELEXA (733 patients)
MULTI-VITAMINS (732 patients)
PREMARIN (731 patients)
AVONEX (726 patients)
FENTANYL (721 patients)
DIOVAN (719 patients)
DIGOXIN (719 patients)
LANTUS (708 patients)
MORPHINE SULFATE (707 patients)
ZANTAC (694 patients)
THALIDOMIDE (673 patients)
REGLAN (673 patients)
TYSABRI (668 patients)
WELLBUTRIN (659 patients)
TRAMADOL HCL (656 patients)
TRAZODONE HCL (655 patients)
SANDOSTATIN LAR (645 patients)
KLONOPIN (643 patients)
ZYRTEC (635 patients)
PREDNISONE TAB (632 patients)
DIAZEPAM (631 patients)
EXJADE (627 patients)
CARBOPLATIN (625 patients)
COMPAZINE (623 patients)
HEPARIN SODIUM INJECTION (620 patients)
WARFARIN SODIUM (614 patients)
ALENDRONATE SODIUM (611 patients)
VALIUM (607 patients)
YAZ (592 patients)
GLUCOPHAGE (584 patients)
AMLODIPINE (581 patients)
MULTI-VITAMIN (581 patients)
DILAUDID (581 patients)
FISH OIL (576 patients)
METOPROLOL TARTRATE (575 patients)
FLEXERIL (572 patients)
VESICARE (568 patients)
MS CONTIN (567 patients)
ASCORBIC ACID (566 patients)
ZELNORM (564 patients)
VITAMIN E (561 patients)
INSULIN (558 patients)
RISPERDAL (554 patients)
CLOZAPINE (551 patients)
ACTONEL (551 patients)
CALCIUM CARBONATE (550 patients)
XELODA (542 patients)
ZYPREXA (536 patients)
SINGULAIR (533 patients)
NAMENDA (530 patients)
ZETIA (519 patients)
AVASTIN (510 patients)
CISPLATIN (500 patients)
LANSOPRAZOLE (500 patients)
TYLENOL (498 patients)
FLOMAX (496 patients)
ALLEGRA (495 patients)
SPIRONOLACTONE (493 patients)
FLONASE (487 patients)
METOCLOPRAMIDE (484 patients)
CHEMOTHERAPEUTICS NOS (480 patients)
ACTOS (480 patients)
FOSAMAX PLUS D (479 patients)
THALOMID (479 patients)
RANITIDINE (476 patients)
TAXOTERE (476 patients)
GLIPIZIDE (473 patients)
VITAMIN B-12 (470 patients)
DIANEAL (470 patients)
BACLOFEN (469 patients)
COREG (467 patients)
YASMIN (467 patients)
CLONIDINE (461 patients)
TYLENOL (CAPLET) (457 patients)
AMITRIPTYLINE HCL (456 patients)
VICTOZA (454 patients)
NITROGLYCERIN (453 patients)
BENADRYL (447 patients)
ARANESP (447 patients)
TAXOL (447 patients)
AMOXICILLIN (444 patients)
ULTRAM (442 patients)
CYCLOPHOSPHAMIDE (442 patients)
ENBREL (438 patients)
CIPROFLOXACIN (437 patients)
METOPROLOL (435 patients)
ELAVIL (435 patients)
COZAAR (434 patients)
HYDROCODONE (428 patients)
EFFEXOR XR (428 patients)
CLINDAMYCIN (426 patients)
PROMETHAZINE (426 patients)
CEPHALEXIN (425 patients)
ARIMIDEX (425 patients)
REMICADE (419 patients)
LEVOXYL (416 patients)
ZITHROMAX (415 patients)
RADIATION THERAPY (415 patients)
DULCOLAX (414 patients)
NAPROXEN (414 patients)
SENOKOT (413 patients)
FERROUS SULFATE TAB (412 patients)
PRISTIQ (411 patients)
TAMOXIFEN CITRATE (410 patients)
FLUOROURACIL (408 patients)
TEMAZEPAM (408 patients)
LOVENOX (404 patients)
FEMARA (401 patients)
SUTENT (401 patients)
FLUCONAZOLE (400 patients)
BONIVA (398 patients)
FAMOTIDINE (395 patients)
TOPAMAX (394 patients)
PEPCID (392 patients)
AVANDIA (391 patients)
CLARITIN (389 patients)
NYSTATIN (386 patients)
ENABLEX (382 patients)
VINCRISTINE (381 patients)
REBIF (380 patients)
ACYCLOVIR (380 patients)
GLYBURIDE (374 patients)
ENALAPRIL MALEATE (373 patients)
HYDROCODONE BITARTRATE (370 patients)
IRON (369 patients)
VITAMINS (369 patients)
ONDANSETRON (368 patients)
ACIPHEX (363 patients)
SENNA (359 patients)
METFORMIN (357 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about CONSTIPATION and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Tehachapi Rentals & Services

Chef and Catering services in Tehachapi
Chiropracter and Massage services in Tehachapi
Event and Wedding Planning services in Tehachapi
Hair Styling services in Tehachapi
Personal Shopping services in Tehachapi
Photography and Videography services in Tehachapi
Private Investigation services in Tehachapi
Website Design services in Tehachapi

Home
Appliance Repair services in Tehachapi
Appraisals services in Tehachapi
Awnings services in Tehachapi
Builder Services services in Tehachapi
Carpentry services in Tehachapi
Cleaning services in Tehachapi
Decks and Porches services in Tehachapi
Electricians services in Tehachapi
Fireplace services in Tehachapi
Generators services in Tehachapi
Greenhouses and Nurseries services in Tehachapi
Handymen services in Tehachapi
Home Security services in Tehachapi
HVAC services in Tehachapi
Insulation services in Tehachapi
Interior Design services in Tehachapi
Landscaping services in Tehachapi
Lawn and Yard services in Tehachapi
Locksmiths services in Tehachapi
Marble and Granite Experts services in Tehachapi
Masonry services in Tehachapi
Moving Services services in Tehachapi
Painters services in Tehachapi
Plumbing services in Tehachapi
Pool and Spa services in Tehachapi
Property Management services in Tehachapi
Roofers services in Tehachapi
Snow Plowing services in Tehachapi
Solar Power Consultants services in Tehachapi
Upholstery services in Tehachapi
Wallpaper services in Tehachapi
Waterproofing services in Tehachapi
Windows services in Tehachapi
Services - Other

© 2014 FactMed, Inc
Privacy Policy
Terms of Use